Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

testosterone nasal gel

A nasal gel containing the human androgen testosterone that is used as a replacement agent for low or missing endogenous testosterone caused by various conditions. Upon intranasal administration of testosterone nasal gel using a pump, testosterone is taken up systemically and is irreversibly converted to dihydrotestosterone (DHT) in target tissues by the enzyme 5-alpha reductase. Testosterone or DHT ligand-androgen receptor complexes act as transcription factor complexes, stimulating the expression of various responsive genes. Testosterone and DHT promote the growth, development and maintenance of male sex organs and the maintenance of secondary sex characteristics. In addition, testosterone is irreversibly converted to estradiol by the enzyme complex aromatase, particularly in the liver and adipose tissue.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Natesto
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search